Ann: Positive AZD0466 clinical data presented by AstraZeneca, page-20

This is a good day for long term holders


ROFL ....not sure many LT holders would agree given the share price remains at 52.5 cents but whatever makes you feel good ?





You like others on here are also "assuming" that it will be a good day for LT shareholders because AstraZeneca are looking at multiple phase 2 AZD0466 trials - what happens if these phase 2 trials don't proceed ? How good will that be for LT shareholders given AstraZeneca looks the best chance IMO of signing a real license deal with huge financial rewards ? We all know how many financial licensing deals have been written off the back of the in house phase 2 DEP trials ? .... oh wait none so far ..... lol